• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . IL-8 as a Causal Link Between Aging and Impaired Influenza Antibody Responses in Older Adults

tetano

Editor, Senior Moderator
J Infect Dis


. 2025 Mar 17:jiaf148.
doi: 10.1093/infdis/jiaf148. Online ahead of print. IL-8 as a Causal Link Between Aging and Impaired Influenza Antibody Responses in Older Adults

Huy Quang Quach[SUP] 1 [/SUP], Krista M Goergen[SUP] 2 [/SUP], Diane E Grill[SUP] 2 [/SUP], Inna G Ovsyannikova[SUP] 1 [/SUP], Gregory A Poland[SUP] 1 3 [/SUP], Richard B Kennedy[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Antibody responses to MF59-adjuvanted (MF59Flu) and high-dose (HDFlu) influenza vaccines have been well-characterized in older adults, yet corresponding cellular immune response data remain limited.
Methods: Blood samples were collected from 106 MF59Flu recipients and 112 HDFlu recipients at four time points: before vaccination (Day 0), and on Days 1, 8, and 28 post-vaccination. Antibody responses were assessed in serum samples using a hemagglutination inhibition assay. Eight pro-inflammatory cytokines and chemokines, including IFN-α2a, IFN-γ, IP-10, MCP-1, MIP-1α, IL-1β, IL-6, and IL-8, were quantified from PBMCs using a multiplex assay. Associations between cytokine/chemokine secretion levels and antibody responses were examined, along with the effect of sex, age, body mass index (BMI), and cytomegalovirus infection status.
Results: Age was positively correlated with IL-8 levels on Day 1 (r = 0.24, p < 0.001) and the change in IL-8 levels from Day 0 to Day 1 (r = 0.16, p = 0.021). Notably, the change in IL-8 levels was negatively associated with Day 28 HAI titers (r = -0.15, p = 0.026). Causal mediation analysis demonstrated that IL-8 exerted significant causal mediation effects on antibody responses at both Day 8 (p = 0.046) and Day 28 (p = 0.0045). No significant effects of other cytokines and chemokines, vaccine type, sex, or BMI on antibody responses were observed.
Conclusion: Our findings underscore IL-8 as a potential mediator of antibody responses to influenza vaccination in older adults, suggesting that IL-8 inhibition could serve as a molecular intervention to improve antibody responses in this high-risk population.

Keywords: HDFlu; Influenza vaccine; MF59Flu; antibody; chemokines; cytokines; older adults.

 
Back
Top